Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…
NCT00032032 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00032032 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer |
| Official title | Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, paclitaxel, radiation therapy |
| Enrollment | 69 |
| Start date | May 1, 2002 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 1, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: